TABUTEAU HERRIOT
SEC insider (Form 3/4/5 filer). CIK 0001219927. Chief Executive Officer at Axsome Therapeutics, Inc. (AXSM). 45 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in NEW YORK, NY.
Companies TABUTEAU HERRIOT has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Director, Officer, 10% Owner, Chief Executive Officer
TABUTEAU HERRIOT
CIK: 0001219927
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Aug 6, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect4.7K shares at avg. $4.95$23K - Aug 6, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect4.7K shares at avg. $213.95$997K - Aug 5, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect45K shares at avg. $212.01$9.5M - Aug 5, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect45K shares at avg. $4.95$223K - Jul 1, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect49.7K shares at avg. $240.25$11.9M - Jul 1, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect49.7K shares at avg. $4.95$246K - Jun 9, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect49.7K shares at avg. $241.01$12.0M - Jun 9, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect49.7K shares at avg. $4.95$246K - Apr 21, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
24.1K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
54.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 4,660 | $4.95 | $23,067 | Direct |
| Aug 6, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 4,660 | $213.95 | $997,007 | Direct |
| Aug 5, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 45,004 | $212.01 | $9,541,298 | Direct |
| Aug 5, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 45,004 | $4.95 | $222,770 | Direct |
| Jul 1, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 49,666 | $240.25 | $11,932,257 | Direct |
| Jul 1, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 49,666 | $4.95 | $245,847 | Direct |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 49,670 | $241.01 | $11,970,967 | Direct |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 49,670 | $4.95 | $245,867 | Direct |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 24,081 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 54,623 | - | - | Direct |
1-10 of 45 transactions